Navya Achieves Reduction in Patient Anxiety with 24 Hour Response Time for Cancer Treatment Options

Treatment Option Response Time and Patient Preferences Key to Decision Making and Emotional Well Being - Presented at San Antonio Breast Cancer Symposium (SABCS) – December 6-7, 2018

CAMBRIDGE, Mass. and SAN ANTONIO, Texas and Mumbai, INDIA – Dec. 6, 2018 - Navya, a clinical informatics and cancer patient services company, founded by graduates of Harvard, MIT Sloan and Stanford in conjunction with Tata Memorial Centre (TMC) and National Cancer Grid (NCG), has been invited to present two clinical impact studies at the prestigious San Antonio Breast Cancer Symposium (SABCS).

The first presentation focuses on a study that reveals providing preliminary reports with treatment recommendations within one day of testing relieves patient anxiety by over 97 percent. The second presentation outlines a study that shows easy-to-understand reports and options for complex treatment allows easier patient decision making. Both studies show the importance of ensuring the emotional well-being of patients and families.

WHAT: Navya at SABCS 2018:
● Dr. Naresh Ramarajan Presenting, “Responding at patient’s time of need: Scaling rapid access to evidence based treatment plan” – Thursday, December 6, 2018, 5-7pm. Program Number: P3-16-01
● Dr. Shalaka Joshi Presenting, “Accuracy of psychosocial assessment in an online surgical decision aid developed for early breast cancer patients with resource and educational constraints” – Friday, December 7, 2018, 5-7pm. Program Number: P5-14-07

WHERE: Henry B. Gonzalez Convention Center, San Antonio, Texas, USA

Navya’s patented system uses clinical informatics, predictive analytics and machine learning. These technologies, which were validated with clinical experts and presented at SABCS 2014, provide patients an upper hand to assess a cancer care decision for themselves, while making available an easy, quick, and preliminary treatment decision pathway, based on an evidence and experience based system, thereby relieving patient anxiety. These are key features of the study being presented at this year’s SABCS.

Promising results have been obtained from patients who have used the Navya Online Expert Opinion System, having been provided with evidence and experience based preliminary reports and expert opinions.

Dr. Naresh Ramarajan, Chief Medical Officer of Navya, said, “System based preliminary reports sent to the patient at a median time of 3.37 hours has proven beneficial, resulting in a 90 percent time savings in comparison to subsequent review by experts. In 10 percent of the preliminary reports, experts added information such as de-/escalating treatment, and additional diagnostic tests.”

Analyzing impact on patients, Dr. Ramarajan added: “Providing preliminary reports with a treatment recommendation within one day, relieves patient anxiety by over 97 percent. However, even a one day delay, increases patient anxiety by over 15 percent. Therefore, each day in waiting matters.”

Over 83 percent of patients who were unrelieved with a three day turnaround, stated that it would matter to them to receive the treatment recommendation in one day. Of note, top academic cancer hospitals in the United States that provide online second opinions have an average turnaround time of 7-14 days. In most developing countries, there is no option to receive a second opinion from tertiary care centers.

Navya’s second presentation focuses on the good response which has been received from women with early-stage breast cancer using the Navya Patient Preference Tool (PPT), which consists of an easy to understand questionnaire, making it simple to understand complex surgical treatment decisions.
Women from socioeconomic backgrounds with resource constraints are commonly not explained the options they have, and hence allowed only limited opinion in their treatment decision making.

“Every patient should be able to advocate her own treatment decisions,” stated Dr. Rajendra Badwe, Director of Tata Memorial Centre and Principal Investigator of the Randomized Controlled Trial on Navya Patient Preference Tools. “By using the Navya PPT, women are able to assess risk-benefit tradeoffs and determine their decision irrespective of education and resource constraints, along with their family and treating oncologist. Decision Aids such as Navya PPT, which account for psychosocial confounders of agency, have the potential to benefit women otherwise marginalized from shared decision making and is especially relevant for women to enable them to be a party to the decision making on matters related to their health and their body.”

About Tata Memorial Centre
Tata Memorial Centre, founded in 1941, leads the Indian subcontinent in cancer care by evidence based practice of oncology, and research and services which are affordable, innovative, and relevant to the needs of the country. Every year nearly 10 million patients visit TMC from all over India and developing countries in Asia, Africa. Approximately, 70 percent of these patients are treated almost free of charge.
Visit: https://tmc.gov.in

About Navya
In 2009, Navya was founded in Cambridge, MA by graduates of Harvard, MIT Sloan, and Stanford. Navya’s patented system uses clinical informatics, predictive analytics and machine learning technologies. It combines several clinical information sources as inputs – and outputs a treatment decision most applicable to a unique patient. For the first time, quick and affordable access to evidence and experience based expert treatment decisions is available to every cancer patient. Navya’s Online Expert Opinion Service has been used by over 26,000 patients in 67 countries.
Visit: https://company.navya.care/

Twitter: https://twitter.com/navyacare
Facebook: https://www.facebook.com/NavyaNetwork?ref=hl
LinkedIn: https://www.linkedin.com/company/navya-network/

Tracy Wemett
BroadPR for Navya
1 Broadway
Cambridage MA 02142
tracy@broadpr.com
+1-617-868-5031

This release was published on openPR.